ChemicalBook > CAS DataBase List > Medroxyprogesterone Acetate

Medroxyprogesterone Acetate

Product Name
Medroxyprogesterone Acetate
CAS No.
71-58-9
Chemical Name
Medroxyprogesterone Acetate
Synonyms
MEDROXYPROGESTERONE 17-ACETATE;PROVERA;Medroxyprogest;Amen;MEDROXYPROGESTRONE ACETATE;Medroxyprogesterone acetate for system suitability CRS;u8839;oragest;veramix;Meprate
CBNumber
CB8130110
Molecular Formula
C24H34O4
Formula Weight
386.52
MOL File
71-58-9.mol
More
Less

Medroxyprogesterone Acetate Property

Melting point:
206-207 °C(lit.)
alpha 
D +61° (in chloroform)
Boiling point:
432.7°C (rough estimate)
Density 
1.0346 (rough estimate)
refractive index 
48 ° (C=1, Dioxane)
storage temp. 
Sealed in dry,2-8°C
solubility 
Practically insoluble in water, freely soluble in methylene chloride, soluble in acetone, sparingly soluble in ethanol (96 per cent)
form 
Solid
color 
White
Water Solubility 
<0.1 g/100 mL at 23 ºC
Merck 
13,5817
BRN 
2066112
BCS Class
2,3,1
Stability:
Stable, but weakly air and light sensitive. Incompatible with strong oxidizing agents.
CAS DataBase Reference
71-58-9(CAS DataBase Reference)
IARC
2B (Vol. 21, Sup 7) 1987
EPA Substance Registry System
Medroxyprogesterone acetate (71-58-9)
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
40-48
Safety Statements 
22-36/37/39-45
WGK Germany 
3
RTECS 
TU5010000
HS Code 
29372390
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H351Suspected of causing cancer

H413May cause long lasting harmful effects to aquatic life

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P273Avoid release to the environment.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P308+P313IF exposed or concerned: Get medical advice/attention.

P405Store locked up.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
46412
Product name
Medroxyprogesterone 17-acetate
Purity
VETRANAL
Packaging
250mg
Price
$74.9
Updated
2024/03/01
Sigma-Aldrich
Product number
1378001
Product name
Medroxyprogesterone acetate
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
200mg
Price
$436
Updated
2024/03/01
Cayman Chemical
Product number
23664
Product name
Medroxyprogesterone 17-acetate
Purity
≥98%
Packaging
500mg
Price
$62
Updated
2024/03/01
Cayman Chemical
Product number
23664
Product name
Medroxyprogesterone 17-acetate
Purity
≥98%
Packaging
1g
Price
$115
Updated
2024/03/01
Sigma-Aldrich
Product number
Y0001484
Product name
Medroxyprogesterone acetate for peak identification
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
y0001484
Price
$153
Updated
2024/03/01
More
Less

Medroxyprogesterone Acetate Chemical Properties,Usage,Production

Description

Medroxyprogesterone Acetate, also known as Medroxyprogesterone 17-acetate or MPA, is a synthetic progestogen and a steroidal progestin. It is derived from the human hormone progesterone. It prevents fertilization and increases the rate of transport of eggs from the fallopian tubes to the uterus in female ferrets when administered prior to ovulation. Medroxyprogesterone 17-acetate reversibly blocks ovulation in rats when injected on the last day of diestrus. It also has anti-androgenic activity in rats, decreasing plasma testosterone levels via induction of hepatic testosterone reductase activity. Medroxyprogesterone 17-acetate exhibits immunosuppressive effects in vitro and in vivo, inhibiting the production of IFN-γ by CD2/CD3/CD28-stimulated peripheral blood mononuclear cells (PBMCs) at concentrations ≥10 nM and extending the survival of rabbit skin allografts. Injectable formulations containing medroxyprogesterone 17-acetate have been used as contraceptives.

Chemical Properties

White or almost white, crystalline powder.

Originator

Provera,Upjohn,US,1959

Uses

Medroxyprogesterone Acetate is a synthetic progesterone receptor agonist that is used to treat amenorrhea (unusual stopping of menstrual periods) and abnormal uterine bleeding.

Definition

ChEBI: Medroxyprogesterone acetate is an acetate ester resulting from the formal condensation of the 17alpha-hydroxy group of medroxyprogesterone with the carboxy group of acetic acid. A widely used progestin in menopausal hormone therapy and in progestogen-only birth control. It has a role as a progestin, an androgen, a female contraceptive drug, a synthetic oral contraceptive, an adjuvant, an inhibitor, an antioxidant and an antineoplastic agent. It is a steroid ester, an acetate ester, a 20-oxo steroid, a 3-oxo-Delta(4) steroid and a corticosteroid. It is functionally related to a medroxyprogesterone.

brand name

Amen (Amarin); Curretab (Solvay Pharmaceuticals); Cycrin (ESI); Provera (Pharmacia & Upjohn);Clinovie;Cliovir;Dep0-clinover;Dep0-map;Depcorlutin;Depo-prodasone;Depo-progevera;Depo-promone;Deporone;Dugen;Farlurin;Farlutale;Gesinal;Gestapuran;Gestapuron;G-farlutal;Hysron;Intex;Luteocrin orale;Luteodione;Luteos;Lutoporal;Metigestene;Nadigest;Nogest;Onco-provera;Perlutest;Petogen;Piermap;Povera;Promone-e;Pronone;Proverone;Provest;Sindomens;Sodelut "g";Supprestal;Verafen;Veramix plus v.

Therapeutic Function

Progestin

World Health Organization (WHO)

A depot preparation containing 150 mg medroxyprogesterone acetate was introduced over 20 years ago for use as a long-acting injectable contraceptive. Subsequently, positive results of carcinogenicity studies carried out in beagle bitches led to refusal of registration in the United States. These findings were later considered irrelevant to contraceptive use in women and the drug was approved by the Food and Drug Administration. Menstrual irregularities are the most common adverse effect associated with depot medroxyprogesterone acetate. Risk-benefit judgements differ significantly from country to country, having regard to differing national circumstances. The preparation is, however, widely available and is included in the WHO Model List of Essential Drugs. (Reference: (WHTAC4) The Use of Essential Drugs, 4th Report of the WHO Expert Committee, 796, , 1990)

General Description

Medroxyprogesterone acetate is an odorless white to off-white microcrystalline powder. It is a synthetic, acetate derivative of the sex hormone progesterone. (NTP, 1992)

Air & Water Reactions

Medroxyprogesterone 17-acetate is sensitive to prolonged exposure to air and light. Insoluble in water.

Reactivity Profile

Flammable and/or toxic gases are generated by the combination of alcohols with alkali metals, nitrides, and strong reducing agents. They react with oxoacids and carboxylic acids to form esters plus water. Oxidizing agents convert them to aldehydes or ketones. Alcohols exhibit both weak acid and weak base behavior. They may initiate the polymerization of isocyanates and epoxides.

Hazard

Possible carcinogen.

Fire Hazard

Flash point data for Medroxyprogesterone 17-acetate are not available; however, Medroxyprogesterone 17-acetate is probably combustible.

Biochem/physiol Actions

Medroxyprogesterone 17-acetate (MPA) is a synthetic progestin used as a contraceptive, in hormone replacement therapy and for the treatment of endometriosis. It is a more potent progestin that the nonacetylated form.

Clinical Use

Progestogen:
Cachexia (unlicensed), contraception, epilepsy, male hypersexuality, malignant neoplasms, respiratory disorders, sickle-cell disease, dysfunctional uterine bleeding, endometriosis

Safety Profile

Suspected carcinogen with experimental carcinogenic, neoplastigenic, tumorigenic, and teratogenic data. Human systemic effects by intravenous route: increased intraocular pressure. Human teratogenic effects by an unspecified route: developmental abnormalities of the urogenital system. Human reproductive effects by multiple routes: spermatogenesis, menstrual cycle changes or dlsorders, postpartum effects, female fertility effects, abortion, newborn behavioral effects. Human mutation data reported. Experimental reproductive effects. A drug for the treatment of secondary amenorrhoea and dysfunctional uterine bleeding. When heated to decomposition it emits acrid smoke and irritating fumes.

Veterinary Drugs and Treatments

In cats, MPA has been used when either castration is ineffective or undesirable to treat sexually dimorphic behavior problems such as roaming, inter-male aggressive behaviors, spraying, mounting, etc. MPA has also been used as a tranquilizing agent to treat syndromes such as feline psychogenic dermatitis and alopecia, but treatment with “true” tranquilizing agents may be preferable.
In humans, parenteral MPA has been used as a long-acting contraceptive in females, to decrease sexually deviant behavior in males, and as an antineoplastic agent for some carcinomas (see Pharmacology section above). Oral MPA is used in human females to treat secondary amenorrhea and to treat abnormal uterine bleeding secondary to hormone imbalances.

Metabolism

Among the first of these substituted 17α-acetoxyprogesterone analogues to be utilized therapeutically was medroxyprogesterone acetate, a 6α-methyl progesterone analogue. This analogue is 25-fold more active than ethisterone. Following oral administration, medroxyprogesterone acetate is completely and rapidly deacetylated by first-pass metabolism to medroxyprogesterone. Medroxyprogesterone is extensively metabolized via pathways similar to those for progesterone, except for 6α-hydroxylation. Most medroxyprogesterone acetate metabolites are excreted in the urine, primarily as glucuronide conjugates. Plasma protein binding for medroxyprogesterone is approximately 86%, primarily to serum albumin, with no binding to SHBG.

References

1. Chang, M.C. Effects of medroxyprogesterone acetate and of ethinyl oestradiol on the fertilization and transportation of ferret eggs. J. Reprod. Fertil. 13(1), 173-174 (1967). DOI:10.1530/JRF.0.0130173
2. Dickmann, Z. Short-and long-term effects of a single injection of depo-medroxyprogesterone acetate (provera) on the vaginal smear, ovulation and mating in the rat. J. Reprod. Fertil. 32(3), 447-451 (1973). DOI:10.1530/JRF.0.0320447
3. Albin, J., Vittek, J., Gordon, G.G., et al. On the mechanism of the anti-androgenic effect of medroxyprogesterone acetate. Endocrinology 93(2), (1973). DOI:10.1210/ENDO-93-2-417
4. Huijbregts, R.P., Michel, K.G., and Hel, Z. Effect of progestins on immunity: Medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception 90(2), 123-129 (2014). DOI:10.1016/j.contraception.2014.02.006
5. Turcotte, J.G., Haines, R.F., Brody, G.L., et al. Immunosuppression with medroxyprogesterone acetate. Transplantation 6(2), 248-260 (1968). DOI:10.1097/00007890-196803000-00010
6. Hofmeyr, G.J., Singata-Madliki, M., Lawrie, T.A., et al. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: A pragmatic randomized controlled trial. Reprod. Health 13, 42 (2016). DOI:10.1186/s12978-016-0153-9
7. Thomas CP, Liu KZ, Vats HS. Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate alpha-ENaC and sgk1 expression in renal collecting duct epithelia. Am J Physiol Renal Physiol. 2006 Feb;290(2):F306-12. Epub 2005 Sep 27. DOI:10.1152/AJPRENAL.00062.2005
8. Braden BB, Talboom JS, Crain ID, Simard AR, Lukas RJ, Prokai L, Scheldrup MR, Bowman BL, Bimonte-Nelson HA. Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats. Neurobiol Learn Mem. 2010Mar;93(3):444-53. DOI:10.1016/j.nlm.2010.01.002

Medroxyprogesterone Acetate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Medroxyprogesterone Acetate Suppliers

Teva Pharmaceutical Industries Ltd. (Teva API)
Tel
--
Fax
--
Email
druginfo@tevausa.com
Country
Israel
ProdList
130
Advantage
58
TEVA PHARMACEUTICAL INDUSTRIES LTD
Tel
--
Fax
--
Email
megan.carroll@tevapharm.com
Country
Israel
ProdList
296
Advantage
58
More
Less

View Lastest Price from Medroxyprogesterone Acetate manufacturers

HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Product
Medroxyprogesterone Acetate 71-58-9
Price
US $100.00-75.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000
Release date
2024-08-21
WUHAN FORTUNA CHEMICAL CO., LTD
Product
Medroxyprogesterone Acetate 71-58-9
Price
US $1.00/Kg/Bag
Min. Order
1KG
Purity
97%~103%,USP39
Supply Ability
500kg/month
Release date
2021-06-05
Sinoway Industrial co., ltd.
Product
Medroxy Progesterone 17-Acetate 71-58-9
Price
US $0.00-0.00/Kg/Bag
Min. Order
1Kg/Bag
Purity
99% up, High Density
Supply Ability
20 tons
Release date
2024-06-27

71-58-9, Medroxyprogesterone AcetateRelated Search:


  • (6-alpha)-17-(acetyloxy)-6-methylpreg-4-ene-3,20-dione
  • 17-(acetyloxy)-6-methyl-(6-alpha)-pregn-4-ene-20-dione
  • 17-(acetyloxy)-6-methyl-20-dion(6alpha)-pregn-4-ene-
  • 17-acetoxy-6-alpha-methylprogesterone
  • 17-alpha-hydroxy-6-alpha-methylpregn-4-ene-3,20-dioneacetate
  • 17-alpha-hydroxy-6-alpha-methyl-progesteronacetate
  • 17-alpha-hydroxy-6-alpha-methylprogesteroneacetate
  • 17-hydroxy-6-alpha-methylpregn-4-ene-3,20-dioneacetate
  • 6-alpha-methyl-17-acetoxyprogesterone
  • 6-alpha-methyl-17-alpha-acetoxypregn-4-ene-3,20-dione
  • 6-alpha-methyl-4-pregnene-3,20-dion-17-alpha-olacetate
  • clinovir
  • depo-medroxyprogesteroneacetate
  • depo-progestin
  • farlutin
  • lutopolar
  • map(steroid)
  • medroxyacetateprogesterone
  • methylacetoxyprogesterone
  • metipregnone
  • nsc-26386
  • oragest
  • perlutex
  • prodasone
  • progestalfa
  • progevera
  • proveradosepak
  • repromap
  • repromix
  • sirprogen
  • u8839
  • veramix
  • 17ALPHA-HYDROXY-6ALPHA-METHYL-4-PREGNENE-3,20-DIONE 17-ACETATE
  • 17-ALPHA-HYDROXY-6-ALPHA-METHYL-4-PREGNENE-3,20-DIONE 17-ALPHA-ACETATE
  • 17alpha-acetoxy-6-alpha-methylpregn-4-ene-3,20-dione
  • 17ALPHA-ACETOXY-6ALPHA-METHYLPROGESTERONE
  • 17a-hydroxy-6a-methyl-4-pregnene-3,20-dione acetate
  • 6-ALPHA-METHYL-17-ACETOPROGESTERONE
  • 6ALPHA-METHYL-17ALPHA-ACETOXYPROGESTERONE
  • 6ALPHA-METHYL-17ALPHA-HYDROXY-PROGESTERONE ACETATE
  • MEDROXYPROGESTERONE 17-ACETATE
  • MEDROXYPROGESTERONE ACETATE
  • hydroxymethylprogesterone acetate
  • DEPO-PROVERA
  • Amen
  • [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
  • [(6S,8R,9S,10R,13S,14S,17R)-17-ethanoyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ethanoate
  • acetic acid [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-3-keto-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester
  • Medroxyprogesterone 17-acetate,17α-Acetoxy-6α-methylprogesterone, 17α-Hydroxy-6α-methyl-4-pregnene-3,20-dione 17-acetate, 6α-Methyl-17α-acetoxyprogesterone, 6α-Methyl-17α-hydroxyprogesterone acetate
  • Medroxyprogesterone Acetate (200 mg)I0D0130.995mg/mg(ai)
  • Medroxyprogesterone Acetate (200 mg)
  • (6α)-17-(Acetyloxy)-6-Methyl-pregn-4-ene-3,20-dione
  • 17α-Acetoxy-6α-Methylpregn-4-ene-3,20-dione
  • 17α-Hydroxy-6α-Methylprogesterone Acetate
  • Meprate
  • Metigestrona
  • NSC 21171
  • Medroxyprogesterone 17-Acetate 17alpha-Acetoxy-6alpha-methylprogesterone 17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione 17-Acetate